The founder and managing director of British veterinary pharmaceutical company Genitrix has been announced as a finalist in the Institute of Director’s (IoD’s) Southern Region “Director of the Year” award.

The founder and managing director of British veterinary pharmaceutical company Genitrix has been announced as a finalist in the Institute of Director’s (IoD’s) Southern Region “Director of the Year” award.

Howard  WilderHoward Wilder founded Genitrix in 1998 following “a successful career” with major corporate companies in the animal health sector. The company manufactures a range of innovative veterinary therapies for dogs, cats, exotics and equines. He has also just achieved the UK’s only formal director qualification, that of Chartered Director, after studying for two years.

Mr Wilder, who is also the outgoing president of NOAH, was shortlisted from a “record number” of entrants to be one of three finalists. He will find out whether he’s won the prestigious award at a gala dinner on March 23.

He said: “I’m thrilled, both to have been shortlisted for the award and to have achieved Chartered Director status. I’ve worked very hard to make Genitrix the best run business in the sector and the award nomination is great recognition of this.

“I’ve been helped by the training I’ve received through the Chartered Director programme. It enables directors of small companies like me to operate to a standard of governance as high as that practiced in public companies.”

IoD regional director Roger Broad said: “The sheer number, scope and quality of entries this year reinforces the view that the IoD Awards are the most prestigious business awards that directors can win. We congratulate all the finalists.”

The IoD Awards are backed by PricewaterhouseCoopers, HSBC, UKTI and Business Link.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz